Anocca’s CEO Reagan Jarvis and CTO Luke Pase are at this conference as part of a 200+ CAR and TCR expert faculty from across the world. Reagan is delivering a Workshop focused on improving TCR-target interactions and enhancing persistence in vivo, and Luke is speaking, and taking part in a panel, in a session covering strategies for accelerating target identification and validation. Reach out if you would like to connect with us in Boston.
Latest news
-
Press release Apr 7, 2022
Renowned Immunotherapy Expert Dr. Michael Kalos joins Anocca’s Scientific Advisory BoardSödertälje, Sweden, 7th April 2022 – Anocca, a biotechnology company using its precision biology platforms …
-
Press release Feb 22, 2022
Anocca Appoints New Senior Management Roles and Expands Scientific TeamsSödertälje, Sweden, February 22, 2022 – Anocca AB, a pioneer in T cell immunotherapy, today …
-
Press release Sep 8, 2021
Anocca appoints Jacob Michlewicz as CFOSödertälje, Sweden, 8 September 2021 – Anocca AB, a leader in unlocking the potential of …